Company intelligence / Profile preview

SiriusXT

Dublin, Leinster, Irelandsiriusxt.com ↗

Ownership: Private
Employees: ~22
Development stage: Commercial

Overview

SiriusXT has commercialized the SXT100, the first laboratory-based soft x-ray microscope capable of high-resolution, 3D imaging of whole cells in their native hydrated state. The system enables non-destructive, label-free visualization at nanometre resolution and has been deployed at leading research institutes such as University College Dublin. Over twenty organizations in Europe and the US are evaluating the instrument for applications in disease research and drug discovery.

Industry: Medical Imaging

Partnerships

University College Dublin School of Physics/Spectroscopy Group/Conway Institute of Biomolecular and Biomedical ResearchHorizon2020/EU Commission

Beyond the preview

Go deeper on SiriusXT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SiriusXT.

Explore the full profile